Medical News Today (MNT)Pain Supplement Glucosamine Linked to Faster Dementia Progression

ℹ️ Observational Association Only Evidence

Glucosamine, widely used for osteoarthritis symptom relief, crosses the blood-brain barrier and incorporates into brain glycans. This study examined whether glucosamine supplementation accelerates hyperglycosylation — a process increasingly active across Alzheimer’s disease stages — using post-mortem brain tissue, mouse models, and a large retrospective patient cohort.

Clinical Considerations:

• Glucosamine use was associated with 25% higher mortality risk in ADRD patients; no signal in MCI patients
• Hyperglycosylation disrupts synaptic signaling and N-glycan processing in memory and cognitive brain regions
• Mouse model findings used an aggressive early-onset model (5xFAD); generalizability to late-onset Alzheimer’s remains limited
• Approximately 6–7% of adults over 70 are prescribed glucosamine; OTC use is substantially higher and untracked

Practice Applications:

• Consider counseling dementia patients currently using glucosamine about these preliminary findings
• Recognize the evidence does not establish causality and no guideline recommendation exists
• Integrate supplement review into dementia follow-up visits, particularly for patients with ADRD diagnoses
• Monitor for future prospective studies before modifying practice patterns broadly